Pharmacoidea’
Pharmacoidea Ltd. specializes in drug discovery, pharmaceutical, and nutraceutical development. The company focuses on innovative research and development in biotechnology, leveraging expertise in micro- and nanotechnology. Their projects often involve collaboration with academic institutions and industry partners to advance health and wellness solutions.
Industries
Nr. of Employees
small (1-50)
Pharmacoidea’
Products
Targeted Drug Delivery
Pharmacoidea develops technologies for selective drug delivery, including methods using cell surface proteoglycans to facilitate the entry of proteins and macromolecules into cells.
Innovative Medicines
Pharmacoidea develops targeted drug delivery systems and gene therapies for neurodegenerative diseases and viral infections.
Gene Therapy
Pharmacoidea is involved in developing gene therapies, focusing on targeted delivery of high molecular weight agents like oligonucleotides and proteins.
Neurodegenerative Disease Research
Pharmacoidea conducts research on neurodegenerative diseases, exploring diagnostic and treatment options, including the use of plant polyphenols and syndecan proteoglycans.
Viral Infection Research
Pharmacoidea develops methods to inhibit viral infections by blocking viral binding to cell surface proteoglycans, with a focus on SARS-CoV-2.
Innovative Nutraceuticals
Pharmacoidea offers dietary supplements with herbal extracts, designed for health protection and based on scientific and clinical evidence.
Targeted Drug Delivery
Pharmacoidea develops technologies for selective drug delivery, including methods using cell surface proteoglycans to facilitate the entry of proteins and macromolecules into cells.
Innovative Medicines
Pharmacoidea develops targeted drug delivery systems and gene therapies for neurodegenerative diseases and viral infections.
Gene Therapy
Pharmacoidea is involved in developing gene therapies, focusing on targeted delivery of high molecular weight agents like oligonucleotides and proteins.
Neurodegenerative Disease Research
Pharmacoidea conducts research on neurodegenerative diseases, exploring diagnostic and treatment options, including the use of plant polyphenols and syndecan proteoglycans.
Viral Infection Research
Pharmacoidea develops methods to inhibit viral infections by blocking viral binding to cell surface proteoglycans, with a focus on SARS-CoV-2.
Innovative Nutraceuticals
Pharmacoidea offers dietary supplements with herbal extracts, designed for health protection and based on scientific and clinical evidence.